WAC 246-305-050
Independent review process. (1)
Information for review.
(a) IROs shall, as necessary, request, accept, and
consider the following information as relevant to a case:
(i) Information that the carrier is required to submit to
the IRO under WAC 284-43-630, including information identified
in that section that is initially missing or incomplete as
submitted by the carrier.
(ii) Other medical, scientific, and cost-effectiveness
evidence which is relevant to the case. For the purposes of
this section, medical, scientific, and cost-effectiveness
evidence has the meaning defined in WAC 246-305-010.
(b) After referral of a case, an IRO shall accept
additional information from the enrollee, the carrier, or a
provider acting on behalf of the enrollee or at the enrollee's
request, provided the information is submitted within five
business days of the referral or, in the case of an expedited
referral, within twenty-four hours. The additional
information must be related to the case and relevant to
statutory criteria.
(c) The IRO shall forward this information to the carrier
within one business day of receipt of the information.
(2) Completion of reviews. Once the insurance
commissioner or designee refers a review, the IRO shall
proceed to final determination unless requested otherwise by
both the carrier and the enrollee or the carrier notifies the
IRO it has reversed its adverse benefit determination.
(3) Time frames for reviews.
(a) An IRO shall make its determination within the
following time limits:
(i) If the review is not expedited, within fifteen days
after receiving necessary information, or within twenty days
after receiving the referral, whichever is earlier. In
exceptional circumstances where information is incomplete, the
determination may be delayed until no later than twenty-five
days after receiving the referral.
(ii) If the review is expedited, as defined in WAC 284-43-540, within seventy-two hours after receiving the
referral. If information on whether a referral is expedited
is not provided to the IRO, the IRO may presume that it is not
an expedited review, but the IRO has the option to seek
clarification from the insurance commissioner or designee.
(b) An IRO shall provide notice to enrollees and the
carrier of the result and basis for the determination,
consistent with subsection (5) of this section, within two
business days of making a determination in regular cases and
immediately in expedited cases.
(c) As used in this subsection, a day is a calendar day,
except that if the period ends on a weekend or an official
Washington state holiday, the time limit is extended to the
next business day. A business day is any day other than
Saturday, Sunday or an official Washington state holiday.
(4) Decision-making procedures.
(a) The independent review process is intended to be
neutral and independent of influence by any affected party or
by state government. The department may conduct
investigations under the provisions of this chapter but the
department has no involvement in the disposition of specific
cases.
(b) Independent review is a paper review process. These
rules do not establish a right to in-person participation or
attendance by the enrollee, the health plan, or the attending
provider nor to reconsideration of IRO determinations.
(c) An IRO shall present cases to reviewers in a way that
maximizes the likelihood of a clear, unambiguous
determination. This may involve stating or restating the
questions for review in a clear and precise manner that
encourages yes or no answers.
(d) If more than one reviewer is used, the IRO shall:
(i) Provide an opportunity for the reviewers to exchange
ideas and opinions about the case with one another, if
requested by a reviewer. This must be done in a manner that
avoids pressure on reviewers to take a position with which
they do not agree and preserves a dissenting reviewer's
opportunity to document the rationale for dissent in the case
file.
(ii) Accept the majority decision of the clinical
reviewers in determining clinical issues.
(e) When a case requires an interpretation regarding the
application of health plan coverage provisions, that
determination must be made by a reviewer or reviewers who are
qualified as contract specialists.
(f) An IRO may uphold an adverse benefit determination if
the patient or any provider refuses to provide relevant
medical records that are available and have been requested
with reasonable opportunity to respond. An IRO may overturn
an adverse benefit determination if the carrier refuses to
provide relevant medical records that are available and have
been requested with reasonable opportunity to respond.
(g) If reviewers are deadlocked, the IRO may add another
reviewer if time allows.
(h) If all pertinent information has been disclosed and
reviewers are unable to make a determination, the IRO shall
decide in favor of the enrollee.
(5) Notification and documentation of determinations. An
IRO shall notify the enrollee and the carrier of the result
and rationale for the determination, including its clinical
basis unless the decision is wholly based on application of
coverage provisions, within the time frame in subsection
(3)(b) of this section.
(a) Documentation of the basis for the determination
shall include references to supporting evidence, and if
applicable, the rationale for any interpretation regarding the
application of health plan coverage provisions.
(b) If the determination overrides the health plan's
medical necessity or appropriateness standards, the rationale
shall document why the health plan's standards are
unreasonable or inconsistent with sound, evidence-based
medical practice.
(c) The written report shall include the qualifications
of reviewers but shall not disclose the identity of the
reviewers.
(d) Notification of the determination must be provided
initially by telephone, e-mail, or facsimile, followed by a
written report by mail. In the case of expedited reviews the
initial notification must be immediate and by telephone.
[Statutory Authority: RCW 43.70.235 and 48.43.535. 11-23-124, § 246-305-050, filed 11/21/11, effective 11/26/11;
01-08-023, § 246-305-050, filed 3/28/01, effective 4/28/01.]